(Reuters) – Moderna Inc said on Thursday it is developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot. The company hopes to eventually add vaccines it is working on for respiratory syncytial virus (RSV) and other respiratory diseases as an annual shot. “We believe this is a very...
Tag: <span>COVID-19</span>
Post
Scientists develop a novel virus-like particle COVID-19 candidate vaccine
U of M researchers have developed a novel virus-like particle vaccine against COVID-19. Having been successfully tested in animals, the novel vaccine — created as part of a study whose findings were recently published in the scientific journal PLOS Pathogens — offers a news approach to a potential human vaccine in the global battle against COVID-19 and its emerging...
Post
Medicine that treats gout could also battle COVID-19
by University of Georgia Ralph Tripp, GRA Eminent Scholar of Vaccine and Therapeutic Studies at the University of Georgia. Credit: UGA As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2. But new research from the University of Georgia offers hope for a viable therapeutic...
Post
Vitamin D and lumisterol emerge as cheap and easily accessible potential treatments for COVID-19
by American Physiological Society Credit: Pixabay/CC0 Public Domain Promising new data from a recent study indicates that active forms of vitamin D can inhibit the replication and expansion of COVID-19. The study’s findings also suggest lumisterol, produced by a chemical reaction in the body using light, works to block COVID-19. Vitamin D and lumisterol metabolites were...
Post
Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera
Researchers in Japan have warned that the Mu (B.1.621) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – appears to be highly resistant to neutralization by sera from convalescent or vaccinated individuals. The B.1.621 variant, first isolated in Colombia in January this year (2021), was classified...
Post
Why do people with diabetes develop severe COVID-19?
by Kelly Malcom, University of Michigan Credit: Pixabay/CC0 Public Domain Throughout the COVID-19 pandemic, clinicians have noted that certain patients are at especially high risk of developing severe illness or dying from coronavirus infection. Type 2 diabetes—a condition affecting more than 10 percent of the U.S. population— is one of the main risk factors for severe...
Post
COVID-19: Monoclonal antibody combo helps high-risk people avoid hospital
Share on Pinterest New research suggests that a combination of two monoclonal antibodies can be an effective COVID-19 treatment. William Taufic/Getty Images A new study finds that a combination of two monoclonal antibodies can help high-risk COVID-19 patients avoid being hospitalized. In a study involving nearly 1,400 people with mild to moderate cases of COVID-19,...
Post
Survey shows healthcare workers more likely to get COVID-19 at home
by Bob Yirka , Medical Xpress SARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIH A team of researchers affiliated with several institutions in Israel has found evidence that suggests healthcare workers are more likely to become infected with COVID-19 at home than on the job. They...
Post
A drug costing less than $2 a day helps in the treatment of severely ill COVID-19 patients
by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) Credit: Pixabay/CC0 Public Domain Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19 patients. This is the finding of a study by investigators at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), published today in the Journal of the American College of...
Post
Information on third mRNA COVID-19 vaccine dose added to NCCN guidance for people with cancer
PLYMOUTH MEETING, PA [August 30, 2021] — The National Comprehensive Cancer Network® (NCCN®)—a nonprofit alliance of leading cancer centers—today announced significant updates to the NCCN: Cancer and COVID-19 Vaccination guidance. This is the fourth version of NCCN’s COVID-19 vaccination guide and incorporates the latest data plus recent approvals from the FDA and CDC regarding a third mRNA...